CCND1 and melanoma: Alterations in the CDKN2A pathway in melanomas can occur due to either copy number changes (deletions of CDKN2A, the amplification of CCND1, and the amplification of CDK4/6), mutations in CDKN2A or CDK4/6, and promoter hypermethylation of CDKN2A [27].